Teladoc Health (NYSE:TDOC) Share Price Crosses Above Fifty Day Moving Average – What’s Next?

Teladoc Health, Inc. (NYSE:TDOC) crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $5.41 and traded as high as $5.53. Teladoc Health shares last traded at $5.3450, with a volume of 6,096,680 shares changing hands.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the company. JPMorgan Chase & Co. reduced their target price on Teladoc Health from $9.00 to $7.00 and set a “neutral” rating for the company in a research note on Friday, March 13th. Oppenheimer reduced their price objective on Teladoc Health from $12.00 to $7.00 and set an “outperform” rating for the company in a research note on Tuesday, March 3rd. Citigroup lowered their target price on Teladoc Health from $9.00 to $6.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 3rd. Weiss Ratings restated a “sell (e+)” rating on shares of Teladoc Health in a research note on Monday, December 29th. Finally, Wells Fargo & Company dropped their price objective on shares of Teladoc Health from $8.00 to $6.00 and set an “equal weight” rating on the stock in a research note on Thursday, February 26th. Six equities research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $7.72.

Teladoc Health Stock Down 3.2%

The company has a current ratio of 2.77, a quick ratio of 2.67 and a debt-to-equity ratio of 0.72. The stock has a market capitalization of $953.53 million, a PE ratio of -4.69 and a beta of 2.13. The stock’s fifty day simple moving average is $5.41 and its 200-day simple moving average is $6.97.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Wednesday, February 25th. The health services provider reported ($0.14) EPS for the quarter, beating the consensus estimate of ($0.19) by $0.05. Teladoc Health had a negative net margin of 7.92% and a negative return on equity of 9.13%. The company had revenue of $642.27 million during the quarter, compared to the consensus estimate of $635.33 million. During the same quarter in the prior year, the company posted ($0.28) earnings per share. The firm’s revenue for the quarter was up .3% on a year-over-year basis. Teladoc Health has set its Q1 2026 guidance at -0.450–0.350 EPS and its FY 2026 guidance at -1.100–0.700 EPS. As a group, sell-side analysts forecast that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Insider Activity at Teladoc Health

In other news, CEO Charles Divita III sold 27,731 shares of the business’s stock in a transaction that occurred on Wednesday, March 11th. The stock was sold at an average price of $5.49, for a total value of $152,243.19. Following the transaction, the chief executive officer owned 364,784 shares in the company, valued at $2,002,664.16. The trade was a 7.06% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.58% of the stock is currently owned by corporate insiders.

Institutional Trading of Teladoc Health

A number of hedge funds have recently bought and sold shares of TDOC. Allianz Asset Management GmbH raised its stake in shares of Teladoc Health by 189.2% during the 3rd quarter. Allianz Asset Management GmbH now owns 1,619,391 shares of the health services provider’s stock worth $12,518,000 after purchasing an additional 1,059,458 shares during the period. Vanguard Group Inc. grew its position in Teladoc Health by 4.2% during the third quarter. Vanguard Group Inc. now owns 21,910,950 shares of the health services provider’s stock valued at $169,372,000 after buying an additional 891,732 shares during the period. Jupiter Asset Management Ltd. purchased a new stake in Teladoc Health during the third quarter worth about $7,576,000. Empowered Funds LLC bought a new stake in Teladoc Health in the second quarter worth about $5,040,000. Finally, Geode Capital Management LLC raised its position in Teladoc Health by 2.1% in the second quarter. Geode Capital Management LLC now owns 4,150,197 shares of the health services provider’s stock worth $36,153,000 after acquiring an additional 84,356 shares during the period. 76.82% of the stock is currently owned by institutional investors.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.